Matches in Wikidata for { <http://www.wikidata.org/entity/Q96609522> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q96609522 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96609522 description "scientific article published on 21 June 2020" @default.
- Q96609522 description "wetenschappelijk artikel" @default.
- Q96609522 description "наукова стаття, опублікована 21 червня 2020" @default.
- Q96609522 name "Efavirenz as a potential drug for the treatment of triple-negative breast cancers" @default.
- Q96609522 name "Efavirenz as a potential drug for the treatment of triple-negative breast cancers" @default.
- Q96609522 type Item @default.
- Q96609522 label "Efavirenz as a potential drug for the treatment of triple-negative breast cancers" @default.
- Q96609522 label "Efavirenz as a potential drug for the treatment of triple-negative breast cancers" @default.
- Q96609522 prefLabel "Efavirenz as a potential drug for the treatment of triple-negative breast cancers" @default.
- Q96609522 prefLabel "Efavirenz as a potential drug for the treatment of triple-negative breast cancers" @default.
- Q96609522 P1433 Q96609522-3935E9F0-28B8-447F-8740-6D64B1721A78 @default.
- Q96609522 P1476 Q96609522-6FE91F76-E8DF-4D25-BBD7-5A295E931EAD @default.
- Q96609522 P2093 Q96609522-08D9EDF5-2AA5-4073-A083-A331708C5804 @default.
- Q96609522 P2093 Q96609522-1594C980-8DDA-4650-AC74-0A7E6716F6D9 @default.
- Q96609522 P2093 Q96609522-2594C89D-88A6-4B73-B3F3-BD11120F0632 @default.
- Q96609522 P2093 Q96609522-5D293AA0-8C47-4444-96A8-77BC45E3D820 @default.
- Q96609522 P2093 Q96609522-E084C7F7-4F1C-4511-A257-ED224070BBBD @default.
- Q96609522 P2860 Q96609522-1D563234-468E-4DF3-B7BA-A35FCC4A7D35 @default.
- Q96609522 P2860 Q96609522-E1E368C7-73EE-4E08-974E-AF72CB9CC534 @default.
- Q96609522 P31 Q96609522-065DBD55-A165-4CA5-BD28-E0C13868F408 @default.
- Q96609522 P356 Q96609522-86E33790-CA8C-43EC-AC57-6FB0FE3FBAB3 @default.
- Q96609522 P50 Q96609522-43346CD2-5280-4F28-8223-5CB0E18E1532 @default.
- Q96609522 P577 Q96609522-A04BDBFE-01BD-4B42-839F-C12C72C2ABFC @default.
- Q96609522 P698 Q96609522-B52E23A9-8791-491E-A46F-174FA265C309 @default.
- Q96609522 P921 Q96609522-8608DB7E-B7EC-49C1-89F8-1A3F91A8974A @default.
- Q96609522 P356 S12094-020-02424-5 @default.
- Q96609522 P698 32566961 @default.
- Q96609522 P1433 Q15754324 @default.
- Q96609522 P1476 "Efavirenz as a potential drug for the treatment of triple-negative breast cancers" @default.
- Q96609522 P2093 "D Rangasamy" @default.
- Q96609522 P2093 "J E Dahlstrom" @default.
- Q96609522 P2093 "P G Board" @default.
- Q96609522 P2093 "P-T Chiou" @default.
- Q96609522 P2093 "S Ohms" @default.
- Q96609522 P2860 Q21045365 @default.
- Q96609522 P2860 Q36791086 @default.
- Q96609522 P31 Q13442814 @default.
- Q96609522 P356 "10.1007/S12094-020-02424-5" @default.
- Q96609522 P50 Q61862823 @default.
- Q96609522 P577 "2020-06-21T00:00:00Z" @default.
- Q96609522 P698 "32566961" @default.
- Q96609522 P921 Q422645 @default.